Atorvastatin cuts anthracycline heart failure

Published Date: 08 Mar 2023

Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.

Read Full News

Latest News

PREVENT Score Alters Hypertension Treatment Over 65

A new analysis shows the 2025 hypertension guideline’s risk-based framework spares a small subgroup from immediate treatment.

Equation Choice May Affect CKD Staging in Primary Care

In the comparison of two equations for CKD stage classification in primary care, the CKD Epidemiology Collaboration equation places a higher proportion of patients in advanced stages.

Hormone Therapy Past Age 65 Tied to Cancer, Vascular Events

A large retrospective cohort study finds some cardiovascular benefits when HT is started earlier but generally supports guidelines discouraging use in older women.

Fast Metabolism May Signal Higher Diabetes Risk

Individuals with a higher estimated basal metabolic rate face a greater chance of developing diabetes and many of its complications, even after accounting for BMI, a study of 341,790 UK adults shows.

Preventing Sudden Death in Romano-Ward Syndrome

Romano-Ward syndrome, the most common congenital long QT disorder, often causes exertion- or stimulus-triggered syncope and sudden death; genetic testing and beta blockers guide prevention.

Why Is Extreme Heat a Mental Health Emergency?

As temperatures rise, so do sleepless nights, medication dangers, and social isolation, compounding vulnerability for those with mental illness.

Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Latest News

A new analysis shows the 2025 hypertension guideline’s risk-based framework spares a small subgroup from immediate treatment.

In the comparison of two equations for CKD stage classification in primary care, the CKD Epidemiology Collaboration equation places a higher proportion of patients in advanced stages.

A large retrospective cohort study finds some cardiovascular benefits when HT is started earlier but generally supports guidelines discouraging use in older women.

Individuals with a higher estimated basal metabolic rate face a greater chance of developing diabetes and many of its complications, even after accounting for BMI, a study of 341,790 UK adults shows.

Romano-Ward syndrome, the most common congenital long QT disorder, often causes exertion- or stimulus-triggered syncope and sudden death; genetic testing and beta blockers guide prevention.

As temperatures rise, so do sleepless nights, medication dangers, and social isolation, compounding vulnerability for those with mental illness.

News All Time

Clinics Closing the Cardiovascular-Mental Health Gap

Integrative clinics reflect a broader movement to close the long-standing gap between cardiovascular medicine and mental health care.

Insomnia Plus OSA Tied to Cerebrovascular Disease Risk

Comorbid insomnia and obstructive sleep apnea are linked to increased long-term risk for cardiovascular and cerebrovascular disease, a new study shows.

Cardiomyopathy-Causing Gene Variants Linked to Risk for AF

An analysis of two large cohort studies finds that carriers of disease-causing variants within genes for three cardiomyopathies were at higher risk for atrial fibrillation.

New US Anti-Fraud Measures: What Doctors Need to Know

The new CMS initiative dubbed CRUSH aims at cracking down on potentially fraudulent orders for molecular diagnostic tests and durable medical equipment.

Prompt Antithrombotics After GI Bleeds Benefits CVD Patients

Stopping antithrombotic therapy may be the most modifiable mechanism behind adverse cardiovascular outcomes after gastrointestinal bleeding.

Spain’s Cardiovascular Risk Standards Introduce Vascular Age

The Spanish Society of Arteriosclerosis releases updated 2026 standards that introduce the concept of vascular age to improve cardiovascular risk assessment.

Fermented Dairy and Metabolic Syndrome: Sex-Specific Link

Different types of dairy products show sex-specific associations with metabolic syndrome and its components, such as levels of lipid markers, a new Finnish study shows.

Photon-Counting CT May Boost In-Stent Restenosis Diagnosis

Ultrahigh-resolution photon-counting detector CT can diagnose coronary in-stent restenosis with higher accuracy than standard-resolution reconstructions, a retrospective study shows.

Telemedicine Platform Yields Notable, Lasting Weight Loss

A real-world study finds that adults with obesity or overweight and related comorbidities who receive antiobesity medications through a telehealth clinic achieve substantial long-term weight loss.

Heart Scans Reveal Hidden Health Issues in Many Older Adults

Advanced heart scans and routine health checks reveal previously unknown heart and other health issues in a vast majority of older adults.

Can Medicine Make Us Live to 150?

Clinical advances in transplants, geroprotective drugs, and metabolomic clocks are shifting focus from lifespan to healthspan — but major biological and ethical limits remain.

Childhood Oral Health Linked to Cardiovascular Disease Later in Life

Kids with numerous dental problems and severe gingivitis were up to 45% more likely to have a heart attack, stroke, or coronary artery disease as adults than kids with less oral disease.

Semaglutide Boosts Insulin Sensitivity in Schizophrenia Care

Semaglutide can mitigate antipsychotic-induced metabolic dysfunction in patients with schizophrenia, prediabetes, and overweight or obesity on second-generation antipsychotics.

1 in 4 Kids at Juvenile Arthritis Onset Have Renal Issues

Acute kidney injury occurs in nearly one quarter of children at the onset of juvenile idiopathic arthritis and increases the risk for long-term kidney damage by more than five times.

New Non-Hormonal Menopause Drug Backed by NICE

NICE has recommended fezolinetant for menopausal hot flushes and night sweats, offering a non-hormonal option when HRT is unsuitable.

VTE Trial: As DOACs Face Off, Apixaban Confirmed Safer

Apixaban halved the risk for bleeding compared with rivaroxaban in the treatment of acute venous thromboembolism in the randomized COBRRA trial.

Recommended News For You

Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy

A pilot study investigates a novel strategy for lowering anxiety and enhancing post-stem cell transplant quality of life.

Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.

Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals

Doctors say lung cancer is still the deadliest cancer, but hope is growing

According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.

Train Eyes so Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke

Recommended Articles For You

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025 

Treating Methemoglobinemia: What You Need to Know Now! 

The Future is Now: Navigating the Precision Revolution in Oncology Treatment 

Uncovering the Causes of Thrombocytosis: A Journey to Improved Health 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants

2.

Cardiopulmonary fitness is key for helping breast cancer patients manage post-diagnosis symptoms, say researchers

3.

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

4.

When does a melanoma metastasize? Implications for management

5.

An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.

1.

Understanding SVR Normal Range: A Guide to Achieving Optimal Health

2.

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late

3.

The Mystery of Carotid Body Tumors: The Facts You Need to Know

4.

Unveiling the Mysteries of Smudge Cells: A New Frontier in Cellular Biology

5.

Everything You Need to Know About RDW-CV: A Comprehensive Guide 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

4.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot